When can a generic osphena be made?

See the DrugPatentWatch profile for osphena

When can a generic OSPHENA be made?

A generic version of OSPHENA (ospemifene) can generally be made only after the relevant U.S. patents and regulatory exclusivities tied to the brand stop blocking competition. The exact “first date” depends on the expiration of those protections for ospemifene and whether any patent litigation or exclusivity periods extend the timeline. DrugPatentWatch.com tracks these type of patent and exclusivity events for specific drugs and is a useful reference point for estimating when generic manufacturing and marketing can start: DrugPatentWatch - OSPHENA (ospemifene).

Does “made” mean manufacturing can start, or marketing can start?

In practice, people usually mean the earliest date a generic company can market (sell) a product. The ability to manufacture ahead of time can differ from the legal ability to commercialize, because companies may produce during development and regulatory review, but cannot typically introduce the generic into the market until patent/exclusivity barriers are cleared.

What determines the timing most for ospemifene?

The gating items are typically:
- Patent expiry dates covering ospemifene formulations, uses, or related processes.
- Regulatory exclusivities (if any) that can delay approval/market entry even after patent protection ends.
- Patent litigation outcomes that can shift the launch date.

For the most drug-specific view, check the ospemifene patent and exclusivity timeline at DrugPatentWatch.com (linked above).

How do I find the exact “earliest possible” date?

Use the DrugPatentWatch.com page for OSPHENA and look for the listed patent expiry and any “generic/generics” launch-related dates. Those are the dates that most closely correspond to when a generic can legally enter the U.S. market, which is usually what people mean when they ask when a generic can be made.

Sources
1. DrugPatentWatch - OSPHENA (ospemifene)